Awards/Legal Rulings
After six years of legal debate involving upwards of 40 attorneys at one point in the trial, the lawsuit and counterclaim were settled out of court. As a result:
- Emory and Triangle Pharmaceuticals were granted exclusive worldwide rights for the test data and intellectual property related to FTC. Emory retained the rights to both 3TC and FTC, thereby securing the intellectual property of their inventors they had sought all along to protect.
- Glaxo and Shire obtained exclusive license from Emory to 3TC.
- Triangle Pharmaceuticals was able to keep its license to FTC, which is now commercialized by Gilead Sciences as a result of their purchase of Triangle.
- Glaxo received an undisclosed payment from Emory and Triangle.
Pertinent Documents
None of the case filings related to this case are accessible and the parties involved kept the settlement of the dispute confidential.
|
